세포유전학 시장 규모, 점유율, 예측, 동향 분석 : 제공별, 기술별, 용도별, 최종 사용자별 예측(-2031년)

Cytogenetics Market Size, Share, Forecast, & Trends Analysis by Offering (Consumables, Instruments, Software, Services), Technique (Comparative Genomic Hybridization, FISH, Karyotyping), Application (Clinical, Research), End User Global Forecast to 2031

The Cytogenetics Market was valued at $2.6 billion in 2023. This market is expected to reach $5.5 billion by 2031 from an estimated $2.9 billion in 2024, at a CAGR of 9.6% during the forecast period of 2024-2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the global cytogenetics market is driven by increasing focus on preventive healthcare measures, prevalence of genetic abnormalities, increasing aging population and subsequent increase in various chronic diseases, growing need to reduce mounting healthcare cost and increasing focus on research and clinical diagnosis. However, lack of awareness about emerging diagnostic technologies, unfavorable reimbursement scenarios and technical limitations and complexities of the equipment are restraining the market's growth.

Furthermore, emerging economies: China, India, South Korea, and Southeast Asia, increasing focus on target-based therapies and increase in predictive and presymptomatic genetic testing are expected to generate market growth opportunities. However, concerns regarding the security & privacy of genetic data, commercialization and scaling of genomic technologies and lack of standardized approaches in genetics are major challenges in the global cytogenetics market.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over years (2021-2024). The key players operating in the cytogenetics market are Thermo Fisher Scientific, Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies, Inc. (U.S.), Revvity, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Applied Spectral Imaging, Inc. (U.S.), Quest Diagnostics Incorporated (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (U.S.), Illumina, Inc. (U.S.) and Sysmex Corporation (Japan)

Among all the offerings studied in this report, the consumables segment is projected to register the highest CAGR of 10.2% during the forecast period. The high CAGR of the segment is attributed to the high demand of consumables for routine cytogenetic testing and research, increased diagnostic applications due to growing prevalence of genetic disorders, technological advancements in consumables and recurring use of consumables.

Among all the techniques studies in this report, in 2024, comparative genomic hybridization accounted for the larger share of 56.7%. technological advancements such as array comparative genomic hybridization and inkjet microarray manufacturing, CGH helps in early disease diagnosis and simplifies diagnostic procedures, optimize probe creation algorithms, clone library development, and its application in identifying diagnostic and therapeutic targets. These factors are contributing to the growth of largest share of the segment.

Among all the applications studied in this report, in 2024, clinical applications segment accounted for the largest share of 82.6%. The segment's larger share can be attributed to the increasing prevalence of genetic disorders and cancers, advancements in diagnostic technologies, rising patient awareness and government initiatives for early diagnosis, growing adoption of personalized medicine, and wide diagnostic applications.

An in-depth analysis of the geographical scenario of the global cytogenetics market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. Asia Pacific is projected to register the highest CAGR of 10.2% during the forecast period. The fastest growth of the market is due to the rising pharmaceutical R&D spending, growth in the biotechnology industry, the increasing prevalence of chronic and infectious diseases, and the rising number of diagnostic laboratories are further expected to drive the cytogenetics market in the region.

Scope of the Report:

Cytogenetics Market Assessment-by Offering

• Consumables
  • Kits & Reagents
• Testing Kits
• Probes
• Other Reagents
  • Other Consumables
• Instruments
• Software
• Services

(Note 1: other reagents include sample preparation and assays)

(Note 2: other consumables include columns, strainers, tips, holders, adapters, caps, digestion vessels, and cartridges.)

Cytogenetics Market Assessment-by Technique

• Comparative Genomic Hybridization
• Fluorescence In Situ Hybridization (FISH)
• Karyotyping
• Other Techniques

(Note: Other Techniques include sister chromatid exchange (SCE))

Cytogenetics Market Assessment-by Application

• Clinical Applications
  • Prenatal & Genetic Testing
  • Oncology
  • Other Clinical Applications
• Research Applications

(Note: Other clinical applications include hematology, predictive and presymptomatic testing, and preimplantation testing)

Cytogenetics Market Assessment-by End User

• Clinical & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Research & Academic Institutes
• Other End Users

(Note: Other end users include agriculture companies, food & beverage companies, and forensics)

Cytogenetics Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • U.K.
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of Asia-Pacific (RoAPAC)
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Market Definition & Scope

• 1.1. Market Definition
• 1.2. Market Ecosystem
• 1.3. Currency & Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection and Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews With Key Opinion Leaders From The Industry
• 2.3. Market Sizing and Forecast
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions for The Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Factors Affecting Market Growth
  • 4.2.1. Impact Analysis of Market Dynamics
    • 4.2.1.1. Prevalence of Genetic Abnormalities and Genetic Disorders
    • 4.2.1.2. Concerns Regarding the Security & Privacy of Genetic Data
  • 4.2.2. Macro Indicators
• 4.3. Key Trends
  • 4.3.1. Use of Chromosome Conformation Capture (3C) In Cytogenetics
  • 4.3.2. Transition From Fluorescence In Situ Hybridization (FISH) To Array Based Techniques
• 4.4. Regulatory Analysis
• 4.5. Porter's Five Forces Analysis

5. Cytogenetics Market Assessment-By Offering

• 5.1. Overview
• 5.2. Consumbles
  • 5.2.1. Kits & Reagents
    • 5.2.1.1. Testing Kits
    • 5.2.1.2. Probes
    • 5.2.1.3. Other Reagents
  • 5.2.2. Other Consumables
• 5.3. Instruments
• 5.4. Software
• 5.5. Services

6. Cytogenetics Market Assessment-By Technique

• 6.1. Overview
• 6.2. Comparative Genomic Hybridization
• 6.3. Fluorescence In Situ Hybridization (FISH)
• 6.4. Karyotyping
• 6.5. Other Techniques

7. Cytogenetics Market Assessment-By Application

• 7.1. Overview
• 7.2. Clinical Applications
  • 7.2.1. Prenatal & Genetic Testing
  • 7.2.2. Oncology
  • 7.2.3. Other Clinical Applications
• 7.3. Research Applications

8. Cytogenetics Market Assessment-By End User

• 8.1. Overview
• 8.2. Clinical & Diagnostic Laboratories
• 8.3. Pharmaceutical & Biotechnology Companies
• 8.4. Research & Academic Institutes
• 8.5. Other End Users

9. Cytogenetics Market Assessment-By Geography

• 9.1. Overview
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. France
  • 9.3.3. Italy
  • 9.3.4. U.K.
  • 9.3.5. Spain
  • 9.3.6. Rest of Europe (Roe)
• 9.4. Asia-Pacific
  • 9.4.1. China
  • 9.4.2. Japan
  • 9.4.3. India
  • 9.4.4. Rest of Asia-Pacific (Roapac)
• 9.5. Latin America
• 9.6. Middle East & Africa

10. Competition Analysis

• 10.1. Overview
• 10.2. Key Growth Strategies
• 10.3. Competitive Benchmarking
• 10.4. Competitive Dashboard
  • 10.4.1. Industry Leaders
  • 10.4.2. Market Differentiators
  • 10.4.3. Vanguards
  • 10.4.4. Emerging Companies
• 10.5. Market Share/Ranking Analysis, By The Key Players, 2023

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and Swot Analysis*)

• 11.1. Thermo Fisher Scientific Inc. (U.S.)
• 11.2. Abbott Laboratories (U.S.)
• 11.3. Agilent Technologies, Inc. (U.S.)
• 11.4. Revvity, Inc. (U.S.)
• 11.5. Applied Spectral Imaging (U.S.)
• 11.6. Bio-Rad Laboratories, Inc. (U.S.)
• 11.7. Sysmex Corporation (Japan)
• 11.8. Illumina, Inc. (U.S.)
• 11.9. F. Hoffman-La-Roche Ltd (Switzerland)
• 11.10. Leica Biosystems (subsidiary of Danaher Corporation) (U.S.)
• 11.11. Quest Diagnostics Incorporated (U.S.)

(Note: Swot Analysis* Will Be Provided of The Top 5 Companies)

12. Appendix

• 12.1. Available Customization
• 12.2. Related Reports